Fabian Niess, Bernhard Strasser, Lukas Hingerl, Viola Bader, Sabina Frese, William T Clarke, Anna Duguid, Eva Niess, Stanislav Motyka, Martin Krššák, Siegfried Trattnig, Thomas Scherer, Rupert Lanzenberger, Wolfgang Bogner
Deuterium metabolic imaging (DMI) is an emerging magnetic resonance technique, for non-invasive mapping of human brain glucose metabolism following oral or intravenous administration of deuterium-labeled glucose. Regional differences in glucose metabolism can be observed in various brain pathologies, such as Alzheimer's disease, cancer, epilepsy or schizophrenia, but the achievable spatial resolution of conventional phase-encoded DMI methods is limited due to prolonged acquisition times rendering submilliliter isotropic spatial resolution for dynamic whole brain DMI not feasible...
April 15, 2024: Human Brain Mapping